Induction of transforming growth factor-β autocrine activity by all-trans-retinoic acid and 1α,25-dihydroxyvitamin D3 in NRP-152 rat prostatic epithelial cells

Journal of Cellular Physiology

Volumn 166, Issue 1, 1996, Pages 231-239

  Danielpour, David ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; FIBRONECTIN; RETINOIC ACID; RETINOID; THROMBOSPONDIN; TRANSFORMING GROWTH FACTOR BETA; VITAMIN D;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; DRUG ACTIVITY; NONHUMAN; PRIORITY JOURNAL; PROSTATE EPITHELIUM; RAT; REGULATORY MECHANISM;

ANIMALS; ANTIBODIES; BINDING, COMPETITIVE; CALCITRIOL; CELL ADHESION MOLECULES; CELL DIVISION; CELL LINE; EPITHELIAL CELLS; EPITHELIUM; FIBRONECTINS; GENE EXPRESSION; MALE; MEMBRANE GLYCOPROTEINS; PROSTATE; RATS; RNA, MESSENGER; THROMBOSPONDINS; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA; TRETINOIN;

ANIMALIA; MAMMALIA;

EID: 0030029703     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4652(199601)166:1<231::AID-JCP24>3.0.CO;2-G     Document Type: Article

References (46)

1. Anzano, M.A., Smith, J.M., Uskokovic, M.R., Peer, C.W., Mullen, L.T., Letterio, J.J., Welsh, M.C., Shrader, M.W., Logsdon, D.L., Driver, C.L., Brown, C.C., Roberts, A.B., and Sporn, M.B. (1994) 1α,25-dihydroxy-16-ene-23-yne-26,27-hexafluorocholecalciferol (Ro24-5531), a new deltinoid (vitamin D analogue) for prevention of breast cancer in the rat. Cancer Res., 54:1653-1656.
2. Ballock, R.T., Heydemann, A., Wakefield, L.M., Flanders, K.C., Roberts, A.B., and Sporn, M.B. (1994) Inhibition of the chondrocyte phenotype by retinoic acid involves upregulation of metalloprotease gene independent of TGF-β. J. Cell. Physiol., 159:340-346.
3. Batova, A., Danielpour, D., Pirisi, L., and Creek, K.E. (1992) Retinoic acid induces secretion of latent transforming growth factor-β1 and - β2 in normal human papillomavirus type 16 immortalized human keratinocytes. Cell Growth Differ., 3:763-772.
4. 3 in chemically induced rat colon carcinogenesis Carcinogenesis, 13:2293-2298.
5. Chomczynski, P., and Sacchi, N. (1987) Single-step method of RNA isolation by acid quanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162:156-159.
6. Church, G., and Gilbert, W. (1984) Genomic sequencing. Proc. Natl. Acad. Sci U.S.A., 81:1991-1995.
7. Colletta, A.A., Wakefield, L.M., Howell, F.V., van Roozendaal, K.E.P., Danielpour, D., Ebbs, S.R., Sporn, M.B., and Baum, M. (1990) Antioestrogens induce the secretion of active transforming growth factor beta from human fetal fibroblasts. Br. J. Cancer, 62:405-409.
8. Danielpour, D. (1993) Improved sandwich enzyme-linked immunosorbent assays for transforming growth factor-beta 1. J. Immunol. Methods, 158:17-25.
9. Danielpour, D., and Roberts, A.B. (1995) Specific and sensitive quantitation of transforming growth factor-β3 by sandwich enzyme-linked immunosorbent assay. J. Immunol. Methods, 180:265-272.
10. Danielpour, D., Dart L.L., Flanders, K.C., Roberts, A.B., and Sporn, M.B. (1989a) Immunodetection and quantitation of the two forms of transforming growth factor-beta (TGF-β1 and TGF-β2) secreted by cells. J. Cell. Physiol., 138:79-86.
11. Danielpour, D., Kim, K.Y., Dart, L.L., Watanabe, S., Roberts, A.B., and Sporn, M.B. (1989b) Sandwich enzyme-linked immunosorbent assays (SELISAs) quantitate and distinguish two forms of transforming growth factor-beta (TGF-β1 and TGF-β2) in complex biological fluids. Growth Factors, 2:61-71.
12. Danielpour, D., Kim, K.Y., Winokur, T.S., and Sporn, M.B. (1991) Differential regulation of the expression of transforming growth factor-βs 1 and 2 by retinoic acid, epidermal growth factor, and dexamethasone in NRK-49F and A549 cells. J. Cell. Physiol , 148:235-244.
13. Danielpour, D., Kadomatsu, K., Anzano, M.A., Smith, J.M., and Sporn, M.E. (1994) Development and characterization of nontumorigenic and tumorigenic epithelial cell lines from rat dorsal-lateral prostate. Cancer Res., 54:3413-3421.
14. Dasch, J.R., Pace, D.R., Waegell, W.O., Inenaga, D., and Ellingsworth, L.E. (1989) Monoclonal antibodies recognize transforming growth factor-β. J Immunol., 42:1536-1541.
15. Fisher, G.J., Tavakkol, A., Griffiths, C.E.M., Elder, J.T., Zhang, Q.Y., Finkel, L., Danielpour, D., Glick, A.B., Higley, H., Ellingsworth, L., and Voorhees, J.J. (1992) Differential modulation of transforming growth factor-beta 1 expression and mucin deposition by retinoic acid and sodium lauryl sulfate in human skin. J. Invest. Dermatol., 98:102-108.
16. Glick, A.B., Flanders, K.C., Danielpour, D., Yuspa, S.H., and Sporn, M.B (1989) Retinoic acid induces transforming growth factor-β2 in cultured keratinocytes and mouse epidermis. Cell Regul., 1:87-97
17. Glick, A.B., McCune, B.K., Abdulkarem, N., Flanders, K.C., Lumadue, J.A., Smith, J M., and Sporn, M.B. (1991) Complex regulation of TGF-β expression by retinoic acid in the vitamin A-deficient rat. Development, 111:1081-1086.
18. Gudas, L.J., Sporn, M.B., and Roberts, A.B. (1994) Cellular biology and biochemistry of the retinoids. In: The Retinoids: Biology Chemistry and Medicine. M B. Sporn, A.B. Roberts, and D.S. Goodman, eds. Raven Press, Ltd, New York, 2nd ed., pp. 443-520.
19. Hanchette, C.L., and Schwartz, G.G. (1992) Geographic patterns of prostate cancer mortality. Cancer, 70:2861-2869.
20. Jakowlew, S.B., Cuberts, J., Danielpour, D., Sporn, M., and Roberts, A.B. (1992) Differential regulation of the expression of transforming growth factor mRNAs by growth factors and retinoic acid in chicken embryo chondrocytes, myocytes and fibroblasts. J. Cell. Physiol., 150:377-384.
21. Kim, S.J., Glick, A.B., Sporn, M.B., and Roberts, A.B. (1989) Promoter sequences of the human transforming growth factor-beta-1 gene J. Biol. Chem., 264:402-408.
22. 3 or antiestrogen to inhibit T-47D human breast cancer cell proliferation. J. Steroid Biochem. Mol. Biol., 39:445-460.
23. Kojima, S., and Rifkin, D.B. (1993) Mechanism of retinoid-induced activation of latent transforming growth factor-β in bovine endothelial cell. J. Cell. Physiol., 155:323-332.
24. 3 and calcipotriol enhance the secretion of transforming growth factor-β1 and -β2 in cultured murine keratinocytes. Growth Factors, 8:153-163.
25. 3 enhances the expression of transforming growth factor-β1 and its latent form binding protein in cultured breast carcinoma cells. Cancer Res., 55:1540-1546.
26. Kyprianou, N., and Issacs, J.T. (1989) Expression of transforming growth factor-β during castration-induced program cell death. Mol. Endocrinol., 3:1515-1522.
27. Lafyatis, R., Lechleider, R., Kim, S.J., Jakowlew, S., Roberts, A.B., and Sporn, M.B. (1990) Structural and functional characteristics of the transforming growth factor beta-3 promoter. A cAMP-responsive element regulates basal and induced transcription. J. Biol. Chem., 265:19128-19136.
28. McKeehan, W.L., and Adams, P.S. (1988) Heparin-binding growth factor/prostatropin attenuates inhibition of rat prostate tumor cell growth by transforming growth factor-β. In Vitro, 24:242-246.
29. 3. Cancer Res., 52:515-520.
30. Noma, T., Glick, A.B., Geiser, A.G., O'Reilly, M.A., Miller, J., Roberts, A.B., and Sporn, M.B. (1991) Molecular cloning and structure of the human transforming growth factor-beta-2 gene promoter. Growth Factors, 4:247-255.
31. Peehl, D.M., Wong, S.T., Bazinet, M., and Stamey, T.A. (1989) In vitro studies of human prostate epithelial cells: Attempts to identify features of malignant cells. Growth Factors, 1:237-250.
32. 3 on primary cultures of human prostatic cells. Cancer Res., 54:805-810.
33. Pienta, K.J., Nguyen, N.M., and Lehr, J.E. (1993) Treatment of prostate cancer in the rat with the synthetic retinoid fenretinide. Cancer Res., 53:224-226.
34. Pollard, M., Luckert, P.H., and Sporn, M B. (1991) Prevention of primary prostate cancer in Lobund-Wistar rats by N-(4-hydroxyphenyl)retinamide. Cancer Res., 51:3610-3611.
35. Pols, H.A., Birkenhagen, J.C., Foekens, J.A., and van Leeuwen, J.P.T.M. (1990) Vitamin D: A modulator of differentiation and proliferation. J. Steroid Biochem. Mol. Biol., 37:873-876.
36. Puissant, C., and Houdebine, M.-L. (1990) An improvement of the single-step method of RNA isolation by acid guanidinium-phenolchloroform extraction. Biotechniques, 8:148-149.
37. Roberts, A.B., and Sporn, M.B. (1990) The transforming growth factor-β. In: Handbook of Experimental Pharmacology: Peptide Growth Factors and Their Receptors. M.B. Sporn and A.B. Roberts, eds. Springer-Verlag, Berlin/Heidelberg/New York/London/Paris/Tokyo/ Hong Kong, pp. 419-472.
38. Roberts, A.B., Kim, S.-J., Noma, T., Glick, A.B., Lafyatis, R , Lechleider, R., Jakowlew, S., Geiser, A., O'Reilly, M.A., Danielpour, D., and Sporn, M.B. (1991) Multiple forms of TGF-β: Differential expression and distinct promoters. CIBA Foundation Symposium No. 157, John Wiley & Sons, Chichester, U.K. pp. 7-29.
39. Schräder, M., Bendik, I., Becker-André, M., and Carlberg, C. (1993) Interaction between retinoic acid and vitamin D signalling pathways. J. Biol. Chem., 268:17830-17836.
40. Schwartz, G.G., and Hulka, B.S. (1990) Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis). Anticancer Res., 10:1307-1312.
41. 3 receptors and action in human prostate cancer cell lines Endocrinology, 132:1952-1960.
42. Slawin, K., Kadmon, D., Park, S.H., Scardino, T.P., Anzano, M., Sporn, M.B., and Thompson, T.C (1993) Dietary fenretinide, a synthetic retinoid, decreases the tumor incidence and the tumor mass of ras + myc-induced carcinoma in the mouse prostate reconstitution model system. Cancer Res., 53:4461-4465.
43. Sporn, M.B., and Newton, D.L. (1979) Chemoprevention of cancer with retinoids. Fed. Proc., 38.2528-2534.
44. Sporn, M.B., and Roberts, A.B (1991) Interactions of retinoids and transforming growth factor-beta in regulation of differentiation and cell proliferation. Mol. Endocrinol., 5:3-7.
45. Stearns, M.E., Wang, M., and Fudge, K. (1993) Liarozole and 13-cis-retinoic acid anti-prostatic tumor activity. Cancer Res., 53:3073-3077.
46. Wilding, G., Zugmeier, G., Knabbe, C., Flanders, K.C., and Gelmann, E. (1989) Differential effects of transforming growth factor β on human prostate cancer cells in vitro. Mol. Cell. Endocrinol., 62:79-87.